Abstract
The aim of this work is to develop and validate the derivative spectrophotometric method for determination of the proton pump inhibitor rabeprazole sodium in pharmaceutical formulations. The technique was applied using water (pH 10.0) as diluent. The first‐order derivative spectra were obtained at N=5, Δλ=4.0 nm, and determinations were made at 304 nm. The method showed high specificity in the presence of formulation excipients and good linearity in the concentration range of 6.0 to 18.0 µg/mL−1. The intra‐ and interday precision data demonstrated the method has good reproducibility [Relative Standard Deviation ((RSD)=1.0 interdays)]. Accuracy was also evaluated and results were satisfactory (mean recovery of 99.15%). The detection and quantitation limits were 0.055 and 0.17 µg/mL−1, respectively. The method was demonstrated to be adequate for routine analysis in quality control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
